Activity record

PGDB_A011913

Assay: bindingTarget: PPIAQC: standardized
Activity overview

inhibition = 95.36 %

TargetPPIA
Time30 min
Assay / ReadoutAlphaLISA / % Inhibition
Assay IDPGDB_AS001219
PatentJP2023161027A
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C008226
Compound IDPGDB_C008226
CompoundC63
Source record IDPGDB_C008226
InChIKeyLBKQCHFVGGGEGB-URXUMGNPSA-N

Assay context

Assay IDPGDB_AS001219
Assay familybinding
Assay systemcell_based
Readout% Inhibition
TechnologyAlphaLISA
Treatment time30 min
TargetPPIA
E3Not specified

Source evidence

Patent IDJP2023161027A
Compound location

C63

C63 enlarged structureC63 location on patent page 174
Activity table
Page 100 · table start
Page 101 · table end